Flusilazole


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D002658 Developmental Disabilities PMID:22382673
MESH:D002972 Cleft Palate PMID:16781842; PMID:28263823
MESH:D004489 Edema, Cardiac PMID:22382673
MESH:D005317 Fetal Growth Retardation PMID:28263823
MESH:D007674 Kidney Diseases PMID:28263823
MESH:D009139 Musculoskeletal Abnormalities PMID:26712470
MESH:D009421 Nervous System Malformations PMID:22634333
MESH:D009436 Neural Tube Defects PMID:27094377
MESH:D011041 Poisoning PMID:22634333
MESH:D018376 Cardiovascular Abnormalities PMID:22382673; PMID:26712470
MESH:D018476 Hypokinesia PMID:26712470
MESH:D019465 Craniofacial Abnormalities PMID:22382673; PMID:32553615
MESH:D020964 Embryo Loss PMID:26712470; PMID:28263823
MESH:D049188 Prenatal Injuries PMID:22664269; PMID:27094377

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.